- In early May 2026, Xometry, Inc. announced a new partnership under which Siemens will invest US$50,000,000 and embed Xometry’s AI-driven manufacturing marketplace into its Siemens Xcelerator software suite, while Xometry also launched expanded single-platform sourcing for precision components used across fast-growing data center infrastructure.
- This combination of Siemens’ software reach with Xometry’s manufacturing intelligence, plus a deeper push into the data center supply chain, could materially increase how often engineers and procurement teams rely on Xometry’s platform for complex, custom parts.
- We’ll now examine how Siemens embedding Xometry’s AI-powered marketplace into its Xcelerator platform could influence the company’s broader investment narrative.
We've uncovered the 14 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
Xometry Investment Narrative Recap
To own Xometry today, you need to believe its AI marketplace can convert deep software integrations and industry specific offerings into sustained buyer growth and improving economics despite ongoing losses. Near term, the key catalyst is how quickly Siemens Xcelerator and data center customers start routing real orders through the platform, while the biggest risk remains Xometry’s lack of consistent GAAP profitability and the possibility of further equity dilution if cash burn persists. The Siemens and data center moves directly touch both.
Against that backdrop, Xometry’s raised 2026 revenue guidance to 27 to 28 percent growth, backed by about 30 percent marketplace growth, is especially relevant. It shows management expectations for higher transaction volumes just as Siemens embeds Xometry’s intelligence into its software and data center buyers gain expanded single platform sourcing. How well those expectations hold up as the Siemens integration rolls out and data center demand evolves will be central to assessing the stock’s near term setup.
Yet even with Siemens on board and guidance higher, investors should be aware that sustained unprofitability and potential dilution risk could still...
Read the full narrative on Xometry (it's free!)
Xometry's narrative projects $1.2 billion revenue and $52.0 million earnings by 2029. This requires 19.0% yearly revenue growth and a $113.7 million earnings increase from -$61.7 million today.
Uncover how Xometry's forecasts yield a $62.33 fair value, a 28% downside to its current price.
Exploring Other Perspectives
Some of the lowest estimate analysts paint a much tougher picture than consensus, assuming only about 16.8 percent annual revenue growth and US$58.6 million of earnings by 2029, so if you are weighing the Siemens partnership against the risk that the integration underdelivers, it is worth recognizing that their more pessimistic narrative could shift meaningfully as this new information filters into updated forecasts.
Explore 4 other fair value estimates on Xometry - why the stock might be worth as much as $75.00!
Decide For Yourself
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
- A great starting point for your Xometry research is our analysis highlighting 1 key reward and 2 important warning signs that could impact your investment decision.
- Our free Xometry research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Xometry's overall financial health at a glance.
Curious About Other Options?
Opportunities like this don't last. These are today's most promising picks. Check them out now:
- Outshine the giants: these 17 early-stage AI stocks could fund your retirement.
- Invest in the nuclear renaissance through our list of 88 elite nuclear energy infrastructure plays powering the global AI revolution.
- Find 51 companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com